BridgeMD
Compares treatment options for Awake Tracheal Intubation
Official title High-flow Nasal Cannula Versus Conventional Oxygen During Awake Tracheal Intubation With Difficult Airways
ClinicalTrials.gov ID: NCT07384494
What this study is testing
- What it's testing
- Study Background Airway management is one of the most fundamental and critical technical procedures in anesthesiology, critical care, and emergency medicine. Difficult airway management remains a major challenge in these fields, particularly when a "cannot intubate, cannot ventilate" scenario occurs during the induction of general anesthesia.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Presence of an anticipated difficult airway;
- Planned awake tracheal intubation;
- Age ≥ 18 years;
- Willingness to participate in the study and provision of written informed consent.
You likely can't join if
- Contraindications to HFNC use, such as severe nasal obstruction or deformity, recent (within 3 months) nasal or skull base surgery, skull base...
- Hemodynamic instability, defined as a mean arterial pressure (MAP) \< 65 mmHg or the need for vasoactive medications to maintain blood pressure;
- Pregnancy;
- Current participation in another treatment clinical trial.
The study team makes the final eligibility decision.
Where it's taking place
- Wuwei, Gansu, China
- Shenzhen, Guangzhou, China
- Baoding, Hebei, China
- Pizhou, Jiangsu, China
- Shanghai, Shanghai Municipality, China
- Neijiang, Sichuan, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Wuwei, Gansu, China; Shenzhen, Guangzhou, China; Baoding, Hebei, China; Pizhou, Jiangsu, China; Shanghai, Shanghai Municipality, China; Neijiang, Sichuan, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.